Target to emerge from chapter 11 by Jan 15, 2024
Company: Core Scientific
What the later record shows
Delivered late · happened January 23, 2024
No passage states the emergence date directly. The new convertible notes were issued on the plan Effective Date, mature five years after it, and have a stated maturity of January 23, 2029, which implies emergence on January 23, 2024, after the January 15 target.
“(ii) mature five (5) years after the Effective Date”
2023-11-16 · core-scientific 8-K exhibit (d603270dex992.htm) View cached copy (2026-11-16)Live source ↗
“On the Effective Date, under the terms of the Plan, the Company issued $260.0 million aggregate principal amount of secured convertible notes due 2029”
2024-01-24 · Core Scientific 8-K/A filed 2024-01-25 View cached copy (2026-08-31)Live source ↗
“The maturity date of the Secured Convertible Notes is January 23, 2029.”
2024-01-24 · Core Scientific 8-K/A filed 2024-01-25 View cached copy (2026-08-31)Live source ↗
Checked November 19, 2026 against filings, releases and reporting published after the claim was made. Quotes are verbatim from the linked documents.
The claim, verbatim
All parties are to use reasonable best efforts to emerge from chapter 11 by January 15, 2024.
Source (primary)
core-scientific 8-K exhibit (d524676dex992.htm) (SEC EDGAR (8-K Ex), press_release)
View cached copy (2026-11-18)Live source ↗
Quote: “subject to all parties' reasonable best efforts Claim Amount to emerge by January 15, 2024”
How we checked this
Checked on November 20, 2026. The cited source supports every part of this claim.
The term sheet refers to all parties' reasonable best efforts to emerge by January 15, 2024, in the context of the chapter 11 plan.
Confirmed in the source:
- All parties are to use reasonable best efforts to emerge from chapter 11 by January 15, 2024
What we did: Read our cached copy of SEC EDGAR (8-K Ex) (https://www.sec.gov/Archives/edgar/data/1839341/000119312523266221/d524676dex992.htm) in full (18,293 characters, retrieved November 18, 2026) and checked each assertion in the claim against it.
Additional evidence
confirms core-scientific 8-K exhibit (d524676dex992.htm)
Quote: “subject to all parties' reasonable best efforts Claim Amount to emerge by January 15, 2024”
confirms Core Scientific 8-K/A filed 2024-01-25
Quote: “On the Effective Date, under the terms of the Plan, the Company issued $260.0 million aggregate principal amount of secured convertible notes due 2029”
confirms core-scientific 8-K exhibit (d603270dex992.htm)
Quote: “(ii) mature five (5) years after the Effective Date”